CLVT (Clarivate) 14-Day RSI : 45.94 (As of Dec. 11, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Clarivate 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-11), Clarivate's 14-Day RSI is 45.94.

The industry rank for Clarivate's 14-Day RSI or its related term are showing as below:

CLVT's 14-Day RSI is ranked better than
68.04% of 2907 companies
in the Software industry
Industry Median: 51.53 vs CLVT: 45.94

Competitive Comparison of Clarivate's 14-Day RSI

For the Information Technology Services subindustry, Clarivate's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarivate's 14-Day RSI Distribution in the Software Industry

For the Software industry and Technology sector, Clarivate's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Clarivate's 14-Day RSI falls into.

Clarivate (NYSE:CLVT) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI

100

–

[ 100

( 1 + Average Gain

Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clarivate (NYSE:CLVT) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Clarivate 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Clarivate's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarivate Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » 14-Day RSI

Comparable Companies

Traded in Other Exchanges

16A:Germany

Address

70 St. Mary Axe, London, GBR, EC3A 8BE

Website

https://www.clarivate.com

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Executives

Michael J Angelakis	director	40 MORRIS AVENUE, BRYN MAWR PA 19010
Bar Veinstein	officer: President, A&G	70 ST. MARY AXE, LONDON X0 EC3 8BA
Saurabh Saha	director	C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Andrew Miles Snyder	director	111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Melanie Margolin	officer: Chief Legal Officer	1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Henry Levy	officer: President, LS&H	70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson	officer: President, IP Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Wendell E. Pritchett	director	TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear	director, officer: Chief Executive Officer-Elect	C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton	officer: Senior VP, Finance/CAO	4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri	officer: Chief Technology Officer	70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins	officer: Executive Vice President/CFO	50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed	officer: President, Science Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Heather Matzke-hamlin	officer: Acting Chief Acctg Officer	4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen	officer: Chief Revenue Officer	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ